Kore Private Wealth LLC Regeneron Pharmaceuticals, Inc. Transaction History

Kore Private Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $179,891 - $222,091	331 New	331 $209,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $56,654 - $68,453	-104 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $20,719 - $27,044	42 Added 67.74%	104 $64,000
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $20,506 - $30,160	61 Added 6100.0%	62 $30,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $274 - $376	1 New	1 $0
Q1 2019 May 16, 2019	SELL	$372.08 - $439.57 $1,488 - $1,758	-4 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$335.82 - $403.04 $1,343 - $1,612	4 New	4 $1,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.